Table 2 Prevalence of non-adherence to the maternal and newborn single doses of nevirapine in Bindura, 2008
Adherence Characteristics | Frequency | 95%CI | |
|---|---|---|---|
| Â | n = 212 | % | Â |
Maternal nevirapine dose | Â | Â | Â |
Swallowed nevirapine at least 2 hrs before delivery | 147 | 69.3 | 62.9-75.3 |
Swallowed nevirapine less than 2 hrs before delivery | 29 | 13.7 | 9.5-18.8 |
Did not swallow nevirapine before delivery | 36 | 17.0 | 12.4-22.5 |
Total maternal non-adherence to NVP | 65 | 30.7 | 24.7-37.1 |
Newborn nevirapine dose | Â | Â | Â |
Swallowed nevirapine within 72 hrs of birth | 155 | 73.1 | 66.8-78.8 |
Swallowed the nevirapine more than 72 hrs after birth | 15 | 7.1 | 4.2-11.2 |
Did not swallow nevirapine after birth | 42 | 19.8 | 14.9-25.6 |
Total newborn baby non-adherence to nevirapine | 57 | 26.9 | 21.2-33.2 |
Combined maternal-infant nevirapine doses | Â | Â | Â |
Mother, baby or both took NVP within recommended time | 121 | 57.1 | 50.3-63.6 |
Mother, baby or both took NVP outside recommended time | 25 | 11.8 | 8.0-16.7 |
Mother, baby or both did not swallow nevirapine | 66 | 31.1 | 25.2-37.6 |
Combined mother-baby non-adherence to NVP | 91 | 42.9 | 36.4-49.7 |